The global market for Liver Cirrhosis Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liver Cirrhosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cirrhosis Therapeutics.

The Liver Cirrhosis Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Cirrhosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liver Cirrhosis Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Liver Cirrhosis Therapeutics Market Report

Report Metric	Details
Report Name	Liver Cirrhosis Therapeutics Market
CAGR	5%
Segment by Type	Oral Injection
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Gilead Sciences, GlaxoSmithKline, Johnson and Johnson, Merck, Roche, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Pharmicell, Salix Pharmaceuticals, Stempeutics Research
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liver Cirrhosis Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liver Cirrhosis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Liver Cirrhosis Therapeutics Market report?

Ans: The main players in the Liver Cirrhosis Therapeutics Market are Gilead Sciences, GlaxoSmithKline, Johnson and Johnson, Merck, Roche, Bristol-Myers Squibb, Conatus Pharmaceuticals, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Pharmicell, Salix Pharmaceuticals, Stempeutics Research

What are the Application segmentation covered in the Liver Cirrhosis Therapeutics Market report?

Ans: The Applications covered in the Liver Cirrhosis Therapeutics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Liver Cirrhosis Therapeutics Market report?

Ans: The Types covered in the Liver Cirrhosis Therapeutics Market report are Oral, Injection

1 Liver Cirrhosis Therapeutics Market Overview

1.1 Product Definition

1.2 Liver Cirrhosis Therapeutics by Type

1.2.1 Global Liver Cirrhosis Therapeutics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Oral

1.2.3 Injection

1.3 Liver Cirrhosis Therapeutics by Application

1.3.1 Global Liver Cirrhosis Therapeutics Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Liver Cirrhosis Therapeutics Market Size Estimates and Forecasts

1.4.1 Global Liver Cirrhosis Therapeutics Revenue 2020-2031

1.4.2 Global Liver Cirrhosis Therapeutics Sales 2020-2031

1.4.3 Global Liver Cirrhosis Therapeutics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Liver Cirrhosis Therapeutics Market Competition by Manufacturers

2.1 Global Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Liver Cirrhosis Therapeutics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Liver Cirrhosis Therapeutics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Liver Cirrhosis Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Liver Cirrhosis Therapeutics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Liver Cirrhosis Therapeutics, Product Type & Application

2.7 Global Key Manufacturers of Liver Cirrhosis Therapeutics, Date of Enter into This Industry

2.8 Global Liver Cirrhosis Therapeutics Market Competitive Situation and Trends

2.8.1 Global Liver Cirrhosis Therapeutics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Liver Cirrhosis Therapeutics Players Market Share by Revenue

2.8.3 Global Liver Cirrhosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Liver Cirrhosis Therapeutics Market Scenario by Region

3.1 Global Liver Cirrhosis Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Liver Cirrhosis Therapeutics Sales by Region: 2020-2031

3.2.1 Global Liver Cirrhosis Therapeutics Sales by Region: 2020-2025

3.2.2 Global Liver Cirrhosis Therapeutics Sales by Region: 2026-2031

3.3 Global Liver Cirrhosis Therapeutics Revenue by Region: 2020-2031

3.3.1 Global Liver Cirrhosis Therapeutics Revenue by Region: 2020-2025

3.3.2 Global Liver Cirrhosis Therapeutics Revenue by Region: 2026-2031

3.4 North America Liver Cirrhosis Therapeutics Market Facts & Figures by Country

3.4.1 North America Liver Cirrhosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Liver Cirrhosis Therapeutics Sales by Country (2020-2031)

3.4.3 North America Liver Cirrhosis Therapeutics Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Liver Cirrhosis Therapeutics Market Facts & Figures by Country

3.5.1 Europe Liver Cirrhosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Liver Cirrhosis Therapeutics Sales by Country (2020-2031)

3.5.3 Europe Liver Cirrhosis Therapeutics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Liver Cirrhosis Therapeutics Market Facts & Figures by Region

3.6.1 Asia Pacific Liver Cirrhosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2020-2031)

3.6.3 Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Liver Cirrhosis Therapeutics Market Facts & Figures by Country

3.7.1 Latin America Liver Cirrhosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Liver Cirrhosis Therapeutics Sales by Country (2020-2031)

3.7.3 Latin America Liver Cirrhosis Therapeutics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Liver Cirrhosis Therapeutics Market Facts & Figures by Country

3.8.1 Middle East and Africa Liver Cirrhosis Therapeutics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Liver Cirrhosis Therapeutics Sales by Type (2020-2031)

4.1.1 Global Liver Cirrhosis Therapeutics Sales by Type (2020-2025)

4.1.2 Global Liver Cirrhosis Therapeutics Sales by Type (2026-2031)

4.1.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2020-2031)

4.2 Global Liver Cirrhosis Therapeutics Revenue by Type (2020-2031)

4.2.1 Global Liver Cirrhosis Therapeutics Revenue by Type (2020-2025)

4.2.2 Global Liver Cirrhosis Therapeutics Revenue by Type (2026-2031)

4.2.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2020-2031)

4.3 Global Liver Cirrhosis Therapeutics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Liver Cirrhosis Therapeutics Sales by Application (2020-2031)

5.1.1 Global Liver Cirrhosis Therapeutics Sales by Application (2020-2025)

5.1.2 Global Liver Cirrhosis Therapeutics Sales by Application (2026-2031)

5.1.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2020-2031)

5.2 Global Liver Cirrhosis Therapeutics Revenue by Application (2020-2031)

5.2.1 Global Liver Cirrhosis Therapeutics Revenue by Application (2020-2025)

5.2.2 Global Liver Cirrhosis Therapeutics Revenue by Application (2026-2031)

5.2.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2020-2031)

5.3 Global Liver Cirrhosis Therapeutics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Gilead Sciences

6.1.1 Gilead Sciences Company Information

6.1.2 Gilead Sciences Description and Business Overview

6.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Product Portfolio

6.1.5 Gilead Sciences Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Company Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Johnson and Johnson

6.3.1 Johnson and Johnson Company Information

6.3.2 Johnson and Johnson Description and Business Overview

6.3.3 Johnson and Johnson Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Johnson and Johnson Liver Cirrhosis Therapeutics Product Portfolio

6.3.5 Johnson and Johnson Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Liver Cirrhosis Therapeutics Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Roche

6.5.1 Roche Company Information

6.5.2 Roche Description and Business Overview

6.5.3 Roche Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Roche Liver Cirrhosis Therapeutics Product Portfolio

6.5.5 Roche Recent Developments/Updates

6.6 Bristol-Myers Squibb

6.6.1 Bristol-Myers Squibb Company Information

6.6.2 Bristol-Myers Squibb Description and Business Overview

6.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Portfolio

6.6.5 Bristol-Myers Squibb Recent Developments/Updates

6.7 Conatus Pharmaceuticals

6.7.1 Conatus Pharmaceuticals Company Information

6.7.2 Conatus Pharmaceuticals Description and Business Overview

6.7.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio

6.7.5 Conatus Pharmaceuticals Recent Developments/Updates

6.8 Gwo Xi Stem Cell Applied Technology

6.8.1 Gwo Xi Stem Cell Applied Technology Company Information

6.8.2 Gwo Xi Stem Cell Applied Technology Description and Business Overview

6.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Portfolio

6.8.5 Gwo Xi Stem Cell Applied Technology Recent Developments/Updates

6.9 Instituto Grifols

6.9.1 Instituto Grifols Company Information

6.9.2 Instituto Grifols Description and Business Overview

6.9.3 Instituto Grifols Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Product Portfolio

6.9.5 Instituto Grifols Recent Developments/Updates

6.10 Intercept Pharmaceuticals

6.10.1 Intercept Pharmaceuticals Company Information

6.10.2 Intercept Pharmaceuticals Description and Business Overview

6.10.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio

6.10.5 Intercept Pharmaceuticals Recent Developments/Updates

6.11 NGM Biopharmaceuticals

6.11.1 NGM Biopharmaceuticals Company Information

6.11.2 NGM Biopharmaceuticals Description and Business Overview

6.11.3 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio

6.11.5 NGM Biopharmaceuticals Recent Developments/Updates

6.12 Norgine

6.12.1 Norgine Company Information

6.12.2 Norgine Description and Business Overview

6.12.3 Norgine Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Norgine Liver Cirrhosis Therapeutics Product Portfolio

6.12.5 Norgine Recent Developments/Updates

6.13 Pharmicell

6.13.1 Pharmicell Company Information

6.13.2 Pharmicell Description and Business Overview

6.13.3 Pharmicell Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Pharmicell Liver Cirrhosis Therapeutics Product Portfolio

6.13.5 Pharmicell Recent Developments/Updates

6.14 Salix Pharmaceuticals

6.14.1 Salix Pharmaceuticals Company Information

6.14.2 Salix Pharmaceuticals Description and Business Overview

6.14.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio

6.14.5 Salix Pharmaceuticals Recent Developments/Updates

6.15 Stempeutics Research

6.15.1 Stempeutics Research Company Information

6.15.2 Stempeutics Research Description and Business Overview

6.15.3 Stempeutics Research Liver Cirrhosis Therapeutics Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Stempeutics Research Liver Cirrhosis Therapeutics Product Portfolio

6.15.5 Stempeutics Research Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Liver Cirrhosis Therapeutics Industry Chain Analysis

7.2 Liver Cirrhosis Therapeutics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Liver Cirrhosis Therapeutics Production Mode & Process Analysis

7.4 Liver Cirrhosis Therapeutics Sales and Marketing

7.4.1 Liver Cirrhosis Therapeutics Sales Channels

7.4.2 Liver Cirrhosis Therapeutics Distributors

7.5 Liver Cirrhosis Therapeutics Customer Analysis

8 Liver Cirrhosis Therapeutics Market Dynamics

8.1 Liver Cirrhosis Therapeutics Industry Trends

8.2 Liver Cirrhosis Therapeutics Market Drivers

8.3 Liver Cirrhosis Therapeutics Market Challenges

8.4 Liver Cirrhosis Therapeutics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Roche

Bristol–Myers Squibb

Conatus Pharmaceuticals

Gwo Xi Stem Cell Applied Technology

Intercept Pharmaceuticals

NGM Biopharmaceuticals

Norgine

PHARMICELL

Salix Pharmaceuticals

Stempeutics Research

List of Tables

Table 1. Global Liver Cirrhosis Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Liver Cirrhosis Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Liver Cirrhosis Therapeutics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Liver Cirrhosis Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Liver Cirrhosis Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Liver Cirrhosis Therapeutics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Liver Cirrhosis Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Liver Cirrhosis Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Liver Cirrhosis Therapeutics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Liver Cirrhosis Therapeutics, Product Type & Application

Table 12. Global Key Manufacturers of Liver Cirrhosis Therapeutics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Liver Cirrhosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cirrhosis Therapeutics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Liver Cirrhosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Liver Cirrhosis Therapeutics Sales by Region (2020-2025) & (K Units)

Table 18. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2020-2025)

Table 19. Global Liver Cirrhosis Therapeutics Sales by Region (2026-2031) & (K Units)

Table 20. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2026-2031)

Table 21. Global Liver Cirrhosis Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2020-2025)

Table 23. Global Liver Cirrhosis Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2026-2031)

Table 25. North America Liver Cirrhosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Liver Cirrhosis Therapeutics Sales by Country (2020-2025) & (K Units)

Table 27. North America Liver Cirrhosis Therapeutics Sales by Country (2026-2031) & (K Units)

Table 28. North America Liver Cirrhosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Liver Cirrhosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Liver Cirrhosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Liver Cirrhosis Therapeutics Sales by Country (2020-2025) & (K Units)

Table 32. Europe Liver Cirrhosis Therapeutics Sales by Country (2026-2031) & (K Units)

Table 33. Europe Liver Cirrhosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Liver Cirrhosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Liver Cirrhosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Liver Cirrhosis Therapeutics Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Liver Cirrhosis Therapeutics Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Liver Cirrhosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Liver Cirrhosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Liver Cirrhosis Therapeutics Sales (K Units) by Type (2020-2025)

Table 51. Global Liver Cirrhosis Therapeutics Sales (K Units) by Type (2026-2031)

Table 52. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2020-2025)

Table 53. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2026-2031)

Table 54. Global Liver Cirrhosis Therapeutics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Liver Cirrhosis Therapeutics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2020-2025)

Table 57. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2026-2031)

Table 58. Global Liver Cirrhosis Therapeutics Price (USD/Unit) by Type (2020-2025)

Table 59. Global Liver Cirrhosis Therapeutics Price (USD/Unit) by Type (2026-2031)

Table 60. Global Liver Cirrhosis Therapeutics Sales (K Units) by Application (2020-2025)

Table 61. Global Liver Cirrhosis Therapeutics Sales (K Units) by Application (2026-2031)

Table 62. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2020-2025)

Table 63. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2026-2031)

Table 64. Global Liver Cirrhosis Therapeutics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Liver Cirrhosis Therapeutics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2020-2025)

Table 67. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2026-2031)

Table 68. Global Liver Cirrhosis Therapeutics Price (USD/Unit) by Application (2020-2025)

Table 69. Global Liver Cirrhosis Therapeutics Price (USD/Unit) by Application (2026-2031)

Table 70. Gilead Sciences Company Information

Table 71. Gilead Sciences Description and Business Overview

Table 72. Gilead Sciences Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Gilead Sciences Liver Cirrhosis Therapeutics Product

Table 74. Gilead Sciences Recent Developments/Updates

Table 75. GlaxoSmithKline Company Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. GlaxoSmithKline Liver Cirrhosis Therapeutics Product

Table 79. GlaxoSmithKline Recent Developments/Updates

Table 80. Johnson and Johnson Company Information

Table 81. Johnson and Johnson Description and Business Overview

Table 82. Johnson and Johnson Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Johnson and Johnson Liver Cirrhosis Therapeutics Product

Table 84. Johnson and Johnson Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Merck Liver Cirrhosis Therapeutics Product

Table 89. Merck Recent Developments/Updates

Table 90. Roche Company Information

Table 91. Roche Description and Business Overview

Table 92. Roche Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Roche Liver Cirrhosis Therapeutics Product

Table 94. Roche Recent Developments/Updates

Table 95. Bristol-Myers Squibb Company Information

Table 96. Bristol-Myers Squibb Description and Business Overview

Table 97. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product

Table 99. Bristol-Myers Squibb Recent Developments/Updates

Table 100. Conatus Pharmaceuticals Company Information

Table 101. Conatus Pharmaceuticals Description and Business Overview

Table 102. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product

Table 104. Conatus Pharmaceuticals Recent Developments/Updates

Table 105. Gwo Xi Stem Cell Applied Technology Company Information

Table 106. Gwo Xi Stem Cell Applied Technology Description and Business Overview

Table 107. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product

Table 109. Gwo Xi Stem Cell Applied Technology Recent Developments/Updates

Table 110. Instituto Grifols Company Information

Table 111. Instituto Grifols Description and Business Overview

Table 112. Instituto Grifols Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Instituto Grifols Liver Cirrhosis Therapeutics Product

Table 114. Instituto Grifols Recent Developments/Updates

Table 115. Intercept Pharmaceuticals Company Information

Table 116. Intercept Pharmaceuticals Description and Business Overview

Table 117. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product

Table 119. Intercept Pharmaceuticals Recent Developments/Updates

Table 120. NGM Biopharmaceuticals Company Information

Table 121. NGM Biopharmaceuticals Description and Business Overview

Table 122. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product

Table 124. NGM Biopharmaceuticals Recent Developments/Updates

Table 125. Norgine Company Information

Table 126. Norgine Description and Business Overview

Table 127. Norgine Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Norgine Liver Cirrhosis Therapeutics Product

Table 129. Norgine Recent Developments/Updates

Table 130. Pharmicell Company Information

Table 131. Pharmicell Description and Business Overview

Table 132. Pharmicell Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Pharmicell Liver Cirrhosis Therapeutics Product

Table 134. Pharmicell Recent Developments/Updates

Table 135. Salix Pharmaceuticals Company Information

Table 136. Salix Pharmaceuticals Description and Business Overview

Table 137. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product

Table 139. Salix Pharmaceuticals Recent Developments/Updates

Table 140. Stempeutics Research Company Information

Table 141. Stempeutics Research Description and Business Overview

Table 142. Stempeutics Research Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Stempeutics Research Liver Cirrhosis Therapeutics Product

Table 144. Stempeutics Research Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Liver Cirrhosis Therapeutics Distributors List

Table 148. Liver Cirrhosis Therapeutics Customers List

Table 149. Liver Cirrhosis Therapeutics Market Trends

Table 150. Liver Cirrhosis Therapeutics Market Drivers

Table 151. Liver Cirrhosis Therapeutics Market Challenges

Table 152. Liver Cirrhosis Therapeutics Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Liver Cirrhosis Therapeutics

Figure 2. Global Liver Cirrhosis Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Liver Cirrhosis Therapeutics Market Share by Type: 2024 & 2031

Figure 4. Oral Product Picture

Figure 5. Injection Product Picture

Figure 6. Global Liver Cirrhosis Therapeutics Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Liver Cirrhosis Therapeutics Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global Liver Cirrhosis Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Liver Cirrhosis Therapeutics Market Size (2020-2031) & (US$ Million)

Figure 13. Global Liver Cirrhosis Therapeutics Sales (2020-2031) & (K Units)

Figure 14. Global Liver Cirrhosis Therapeutics Average Price (USD/Unit) & (2020-2031)

Figure 15. Liver Cirrhosis Therapeutics Report Years Considered

Figure 16. Liver Cirrhosis Therapeutics Sales Share by Manufacturers in 2024

Figure 17. Global Liver Cirrhosis Therapeutics Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Liver Cirrhosis Therapeutics Players: Market Share by Revenue in Liver Cirrhosis Therapeutics in 2024

Figure 19. Liver Cirrhosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Liver Cirrhosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Liver Cirrhosis Therapeutics Sales Market Share by Country (2020-2031)

Figure 22. North America Liver Cirrhosis Therapeutics Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Liver Cirrhosis Therapeutics Sales Market Share by Country (2020-2031)

Figure 26. Europe Liver Cirrhosis Therapeutics Revenue Market Share by Country (2020-2031)

Figure 27. Germany Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Liver Cirrhosis Therapeutics Revenue Market Share by Region (2020-2031)

Figure 34. China Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Country (2020-2031)

Figure 45. Latin America Liver Cirrhosis Therapeutics Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Liver Cirrhosis Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Liver Cirrhosis Therapeutics by Type (2020-2031)

Figure 55. Global Revenue Market Share of Liver Cirrhosis Therapeutics by Type (2020-2031)

Figure 56. Global Liver Cirrhosis Therapeutics Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Liver Cirrhosis Therapeutics by Application (2020-2031)

Figure 58. Global Revenue Market Share of Liver Cirrhosis Therapeutics by Application (2020-2031)

Figure 59. Global Liver Cirrhosis Therapeutics Price (USD/Unit) by Application (2020-2031)

Figure 60. Liver Cirrhosis Therapeutics Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions